Company news

Endonovo Therapeutics, Inc. news in 2023

Endonovo Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million

December 3, 2023

Endonovo's SofPulse® Secures Taiwan FDA Approval

October 11, 2023

Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution

August 21, 2023

Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update

August 7, 2023

New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.

June 21, 2023

Endonovo Pending Agreement to Develop Telehealth Division

June 6, 2023

Endonovo Launches SofPulse® into the Veterans Administration

May 1, 2023

Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies

April 24, 2023

Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman

April 12, 2023

Endonovo Announces Partnership with Santana Lead Singer Andy Vargas

April 9, 2023

Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company

March 28, 2023

Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan

March 22, 2023

Olympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgery

March 14, 2023

Endonovo Announces Distribution Agreement with Academy Medical

March 5, 2023

Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg

February 28, 2023

Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off

January 31, 2023

Endonovo Partners with International Distributor for SofPulse® Line

January 26, 2023

New Details on Endonovo’s Spin-Off of SofPulse, Inc.

January 19, 2023

Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company

January 9, 2023

Endonovo Targets Dept. of Defense, VA & Federal Contracts

January 3, 2023